Baxter International

BAX · NYSE · USD

$23.49Change from previous close: −0.63%Absolute change: −$0.15

Close · October 2, 2026

At a glance

Revenue growth
+5.72%
2025 vs 2024
Net margin
-8.5%
2024: -6.1%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Annual
Item20252024202320222021
Total revenue11,24410,63610,36010,057—
Cost of revenue7,8656,6526,2106,508—
Gross profit3,3793,9844,1503,549—
Selling, general and administrative2,8902,9672,9533,097—
Research and development518590518450—
Operating income177439707-33.0—
EBIT-215119750-2,835—
EBITDA7661,1161,734-1,763—
Interest expense290408508413—
Pre-tax income-505-289242-3,248—
Income tax39537.061.0-135—
Net income-957-6492,656-2,433—
Net income to common shareholders-957-6492,656-2,433—
Basic EPS-1.87-1.275.25-4.83—
Diluted EPS-1.87-1.275.25-4.83—
Average shares (basic)513510506504—
Average shares (diluted)513510506504—